Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care
- PMID: 30947728
- PMCID: PMC6449897
- DOI: 10.1186/s12916-019-1310-0
Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a major cause of mortality. Patients with advanced disease often have a poor quality of life, such that guidelines recommend providing palliative care in their last year of life. Uptake and use of palliative care in advanced COPD is low; difficulty in predicting 1-year mortality is thought to be a major contributing factor.
Methods: We identified two primary care COPD cohorts using UK electronic healthcare records (Clinical Practice Research Datalink). The first cohort was randomised equally into training and test sets. An external dataset was drawn from a second cohort. A risk model to predict mortality within 12 months was derived from the training set using backwards elimination Cox regression. The model was given the acronym BARC based on putative prognostic factors including body mass index and blood results (B), age (A), respiratory variables (airflow obstruction, exacerbations, smoking) (R) and comorbidities (C). The BARC index predictive performance was validated in the test set and external dataset by assessing calibration and discrimination. The observed and expected probabilities of death were assessed for increasing quartiles of mortality risk (very low risk, low risk, moderate risk, high risk). The BARC index was compared to the established index scores body mass index, obstructive, dyspnoea and exacerbations (BODEx), dyspnoea, obstruction, smoking and exacerbations (DOSE) and age, dyspnoea and obstruction (ADO).
Results: Fifty-four thousand nine hundred ninety patients were eligible from the first cohort and 4931 from the second cohort. Eighteen variables were included in the BARC, including age, airflow obstruction, body mass index, smoking, exacerbations and comorbidities. The risk model had acceptable predictive performance (test set: C-index = 0.79, 95% CI 0.78-0.81, D-statistic = 1.87, 95% CI 1.77-1.96, calibration slope = 0.95, 95% CI 0.9-0.99; external dataset: C-index = 0.67, 95% CI 0.65-0.7, D-statistic = 0.98, 95% CI 0.8-1.2, calibration slope = 0.54, 95% CI 0.45-0.64) and acceptable accuracy predicting the probability of death (probability of death in 1 year, n high-risk group, test set: expected = 0.31, observed = 0.30; external dataset: expected = 0.22, observed = 0.27). The BARC compared favourably to existing index scores that can also be applied without specialist respiratory variables (area under the curve: BARC = 0.78, 95% CI 0.76-0.79; BODEx = 0.48, 95% CI 0.45-0.51; DOSE = 0.60, 95% CI 0.57-0.61; ADO = 0.68, 95% CI 0.66-0.69, external dataset: BARC = 0.70, 95% CI 0.67-0.72; BODEx = 0.41, 95% CI 0.38-0.45; DOSE = 0.52, 95% CI 0.49-0.55; ADO = 0.57, 95% CI 0.54-0.60).
Conclusion: The BARC index performed better than existing tools in predicting 1-year mortality. Critically, the risk score only requires routinely collected non-specialist information which, therefore, could help identify patients seen in primary care that may benefit from palliative care.
Keywords: COPD; Mortality; Palliative care; Prediction; Risk score.
Conflict of interest statement
Ethics approval and consent to participate
The protocol for this research was approved by the Independent Scientific Advisory Committee (ISAC) for MHRA Database Research (protocol number 17_083). Generic ethical approval for observational research using CPRD with approval from ISAC has been granted by a Health Research Authority (HRA) Research Ethics Committee (East Midlands – Derby, REC reference number 05/MRE04/87). Linked pseudonymised data was provided for this study by CPRD. Data is linked by NHS Digital, the statutory trusted third party for linking data, using identifiable data held only by NHS Digital. Select practices consent to this process at a practice level with individual patients having the right to opt-out.
Consent for publication
Not applicable.
Competing interests
All authors have completed the ICMJE uniform disclosure form at
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.Respir Med. 2018 May;138:150-155. doi: 10.1016/j.rmed.2018.04.003. Epub 2018 Apr 12. Respir Med. 2018. PMID: 29724388
-
External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.Int J Chron Obstruct Pulmon Dis. 2019 Oct 24;14:2395-2407. doi: 10.2147/COPD.S212381. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31749613 Free PMC article.
-
Discriminative and predictive properties of multidimensional prognostic indices of chronic obstructive pulmonary disease: a validation study in Taiwanese patients.Respirology. 2014 Jul;19(5):694-9. doi: 10.1111/resp.12313. Epub 2014 May 6. Respirology. 2014. PMID: 24797671
-
Case-finding and improving patient outcomes for chronic obstructive pulmonary disease in primary care: the BLISS research programme including cluster RCT.Southampton (UK): NIHR Journals Library; 2021 Nov. Southampton (UK): NIHR Journals Library; 2021 Nov. PMID: 34780128 Free Books & Documents. Review.
-
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4. Cochrane Database Syst Rev. 2016. PMID: 27990628 Free PMC article. Review.
Cited by
-
Predicting mortality in The Irish Longitudinal Study on Ageing (TILDA): development of a four-year index and comparison with international measures.BMC Geriatr. 2022 Jun 21;22(1):510. doi: 10.1186/s12877-022-03196-z. BMC Geriatr. 2022. PMID: 35729488 Free PMC article.
-
The DOSE index in chronic obstructive pulmonary disease: evaluating healthcare costs.BMC Pulm Med. 2024 Nov 8;24(1):560. doi: 10.1186/s12890-024-03368-0. BMC Pulm Med. 2024. PMID: 39516765 Free PMC article.
-
Development and validation of a prediction index for recent mortality in advanced COPD patients.NPJ Prim Care Respir Med. 2022 Jan 13;32(1):2. doi: 10.1038/s41533-021-00263-7. NPJ Prim Care Respir Med. 2022. PMID: 35027570 Free PMC article.
-
PUMA screening tool to detect COPD in high-risk patients in Chinese primary care-A validation study.PLoS One. 2022 Sep 9;17(9):e0274106. doi: 10.1371/journal.pone.0274106. eCollection 2022. PLoS One. 2022. PMID: 36084011 Free PMC article.
-
Clinical Analytics Prediction Engine (CAPE): Development, electronic health record integration and prospective validation of hospital mortality, 180-day mortality and 30-day readmission risk prediction models.PLoS One. 2020 Aug 27;15(8):e0238065. doi: 10.1371/journal.pone.0238065. eCollection 2020. PLoS One. 2020. PMID: 32853223 Free PMC article.
References
-
- Snell N, et al. S32 epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: findings from the British lung foundation’s ‘respiratory health of the nation’ project. Thorax. 2016;71:A20.1–A2A20. doi: 10.1136/thoraxjnl-2016-209333.38. - DOI
-
- GBD 2015 Chronic Respiratory Disease Collaborators, J. B et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706. doi: 10.1016/S2213-2600(17)30293-X. - DOI - PMC - PubMed
-
- National Institute for Health and Care Excellence (NICE). Chronic Obstructive Pulmonary Disease in over 16s: diagnosis and managment (NICE Guideline). 2018. - PubMed
-
- National Council for Palliative Care . Commissioning End of Life Care. 2011.
